2
Clinical Trials associated with HRS-9815评价HRS-9815用于前列腺癌患者PET/CT成像的安全性、药代动力学及辐射剂量学I期临床研究
[Translation] Phase I clinical study to evaluate the safety, pharmacokinetics and radiation dosimetry of HRS-9815 for PET/CT imaging in patients with prostate cancer
本研究的目的是在前列腺癌成年患者中评价HRS-9815用于PET/CT成像的的安全性、PK特征、辐射剂量学特征
[Translation] The purpose of this study is to evaluate the safety, PK, and radiation dosimetry characteristics of HRS-9815 for PET/CT imaging in adult patients with prostate cancer.
Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics and Radiation Dosimetry of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer.
The study is being conducted to evaluate the the safety, pharmacokinetics, radiation dosimetry of HRS-9815 for PET/CT imaging in adult patients with prostate cancer.
100 Clinical Results associated with HRS-9815
100 Translational Medicine associated with HRS-9815
100 Patents (Medical) associated with HRS-9815
100 Deals associated with HRS-9815